| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/18/2003 | WO2003029427A3 Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2 |
| 12/18/2003 | WO2003026692A3 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 12/18/2003 | WO2003025163A3 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
| 12/18/2003 | WO2003025146A3 Production of a transgenic avian by cytoplasmic injection |
| 12/18/2003 | WO2003024304A3 Detection and treatment of cancers of the liver |
| 12/18/2003 | WO2003023057A3 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells |
| 12/18/2003 | WO2003014342A3 Identification of a dna variant associated with adult type hypolactasia |
| 12/18/2003 | WO2003009817B1 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 12/18/2003 | WO2003008930A3 Lfa-1 binding agents that recognize neoepitopes |
| 12/18/2003 | WO2003006619A3 Calcineurin modulators |
| 12/18/2003 | WO2003006045A3 Cxcl10 treatment of secondary tissue degeneration |
| 12/18/2003 | WO2003000864A8 Nucleic acid-associated proteins |
| 12/18/2003 | WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein |
| 12/18/2003 | WO2002092788A3 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 12/18/2003 | WO2002083030A3 Bifunctional energy-reversible acyl-compositions |
| 12/18/2003 | WO2002057423A3 Isolating cells expressing secreted proteins |
| 12/18/2003 | WO2002040720A8 Compositions and methods relating to ovary specific genes and proteins |
| 12/18/2003 | WO2001034829A3 Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
| 12/18/2003 | US20030232972 Rationally designed antibodies |
| 12/18/2003 | US20030232971 Tumour necrosis factor binding ligands |
| 12/18/2003 | US20030232970 Monoclonal antibody for treatment of tumor disorders; antitumor agents |
| 12/18/2003 | US20030232395 Recombination of nucleic acid library members |
| 12/18/2003 | US20030232387 Antibodies that bind alphaE integrin |
| 12/18/2003 | US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders |
| 12/18/2003 | US20030232334 Novel compositions and methods for cancer |
| 12/18/2003 | US20030232333 Cleaving single-stranded nucleic acid sequences at a desired location, using a restriction endonuclease that is active at the chosen temperature |
| 12/18/2003 | US20030232330 Detection and identification of enteric bacteria |
| 12/18/2003 | US20030232328 Method of detecting antibodies to HCV |
| 12/18/2003 | US20030232326 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 12/18/2003 | US20030232323 Identifying an agents which inhibit the interaction between a PD-1 ligand and a PD-1 polypeptide, from test agents, determining whether interaction is inhibited, and such agent unable to inhibit interaction, modulates immune response |
| 12/18/2003 | US20030232061 For therapy of respiratory tract infection in a mammal |
| 12/18/2003 | US20030232054 Novel nucleic acids and polypeptides |
| 12/18/2003 | US20030232052 Antibodies that bind to an epitope on the Huntington's disease protein |
| 12/18/2003 | US20030232051 Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma |
| 12/18/2003 | US20030232049 Multispecific reagent for selectively stimulating cell surface receptors |
| 12/18/2003 | US20030232048 Methods for treating chronic obstructive pulmonary disease (COPD) |
| 12/18/2003 | US20030232046 Modified "S" antibodies |
| 12/18/2003 | US20030232045 Methods and compositions for in vivo clearance of pathogens |
| 12/18/2003 | US20030232037 Immunology, gene therapy |
| 12/18/2003 | US20030232022 P. gingivalis antigenic composition |
| 12/18/2003 | US20030232010 Improved cytotoxic therapy |
| 12/18/2003 | US20030232009 Used to block undesirable immune reactions in patients with transplant rejection and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and autoimmune diabetes |
| 12/18/2003 | US20030230532 Use of a clathrate modifier, to promote passage of proteins during nanofiltration |
| 12/18/2003 | CA2489195A1 Anti-addl antibodies and uses thereof |
| 12/18/2003 | CA2489180A1 Method for mapping and eliminating t-cell epitopes |
| 12/18/2003 | CA2488682A1 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 12/18/2003 | CA2487428A1 Cd200-receptor mediated modulation of bone development |
| 12/18/2003 | CA2487420A1 Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents |
| 12/18/2003 | CA2487147A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 12/17/2003 | EP1371986A1 Diagnosis of Alzheimer's disease based on the hAbeta42:hAbeta40 ratio |
| 12/17/2003 | EP1371983A1 Immunoassay, reagent for immunoassay, and production method of the same |
| 12/17/2003 | EP1371728A1 Gene encoding adseverin |
| 12/17/2003 | EP1371665A1 Process for selectively isolating IgY antibodies from egg yolk of an anseriform bird and IgY antibodies obtained thereby |
| 12/17/2003 | EP1371660A1 Vaccine |
| 12/17/2003 | EP1370684A2 Polynucleotides related to colon cancer |
| 12/17/2003 | EP1370676A2 Mouse cytokine receptor |
| 12/17/2003 | EP1370674A2 Enzymes having alpha amylase activity and methods of use thereof |
| 12/17/2003 | EP1370662A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 12/17/2003 | EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same |
| 12/17/2003 | EP1370655A2 Secreted human proteins |
| 12/17/2003 | EP1370654A2 Chimpanzee erythropoietin (chepo) immunoadhesins |
| 12/17/2003 | EP1370640A1 Lactic acid bacteria as agents for treating and preventing allergy |
| 12/17/2003 | EP1370589A2 Rationally designed antibodies |
| 12/17/2003 | EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 12/17/2003 | EP1370586A2 Nuclear hormone receptor ligand binding domain |
| 12/17/2003 | EP1370585A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 12/17/2003 | EP1370584A2 Nuclear hormone receptor ligand binding domain |
| 12/17/2003 | EP1370583A1 Polypeptides and nucleic acids for bolekine |
| 12/17/2003 | EP1370580A2 A new essential downstream component of the wingless signalling pathway |
| 12/17/2003 | EP1370575A2 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 12/17/2003 | EP1370297A2 Method and composition |
| 12/17/2003 | EP1370292A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 12/17/2003 | EP1370290A2 Molecular antigen array |
| 12/17/2003 | EP1370289A2 Method for producing a vaccine containing autologous antibodies |
| 12/17/2003 | EP1370288A2 Method for treating thrombocytopenia with monoclonal ivig |
| 12/17/2003 | EP1370286A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 12/17/2003 | EP1066043B1 Materials for the treatment of conditions involving mast cells, basophils and eosinophils |
| 12/17/2003 | EP1007074B1 Hypothalamus-specific polypeptides |
| 12/17/2003 | EP0954580B1 Human sdf-5 protein and compositions |
| 12/17/2003 | EP0936923B1 SUPPRESSION OF TNFalpha AND IL-12 IN THERAPY |
| 12/17/2003 | EP0792363B1 Novel pesticidal proteins and strains |
| 12/17/2003 | EP0763101B1 Nucleic acid sequences and expression systems for heparinase iii derived from flavobacterium heparinum |
| 12/17/2003 | EP0690132B1 Anti-hiv monoclonal antibody |
| 12/17/2003 | EP0672131B1 A novel cell cycle control protein |
| 12/17/2003 | EP0641218B1 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality |
| 12/17/2003 | EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 12/17/2003 | CN1462192A Blood cell production via activation of hemeglobin scavenger receptor |
| 12/17/2003 | CN1461752A Humon leukemia related reverse transcrigt virus genome coded protein and polypeptide sequence and its application |
| 12/17/2003 | CN1131240C Chromosome 21 gene marker, compositions and methods using same |
| 12/16/2003 | US6664444 1-SST (sucrose:sucrose 1-fructosyl-transferase) enzyme encoding cDNA sequence; transformation; highly linear polysaccharide chains; use in food, feed and beverages |
| 12/16/2003 | US6664385 Kidney injury-related molecules |
| 12/16/2003 | US6664379 Nuclease inhibitor cocktail |
| 12/16/2003 | US6664376 Chimeric polypeptide molecules |
| 12/16/2003 | US6664375 Nucleotide sequences coding binding protein for use in the treatment of alzheimer's disease and nervous system disorders |
| 12/16/2003 | US6664372 Solution phase synthesis on a soluble homopolymer support by reacting tert-butoxycarbonyl-protected aza-amino acids with bis(pentafluorophenyl) carbonate as carbonyl activation element and coupling to support; combinatorial chemistry |
| 12/16/2003 | US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 12/16/2003 | US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72 |
| 12/16/2003 | US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 12/16/2003 | US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 12/16/2003 | US6664087 Isolated human kinase proteins |